Humacyte, Inc.
Clinical trials sponsored by Humacyte, Inc., explained in plain language.
-
Lab-Made blood vessel could free dialysis patients from catheters
Disease control OngoingThis Phase 3 trial tests a lab-grown blood vessel (ATEV) against the standard surgically created fistula in 121 women with end-stage kidney disease who need dialysis. The goal is to see if the ATEV allows more days without a catheter and reduces infections over 12 months. If succ…
Phase: PHASE3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Desperate patients get access to experimental Lab-Made vessel
Disease control TEMPORARILY_NOT_AVAILABLEThis program allows individual patients with vascular disease or end-stage kidney disease on dialysis to request an experimental lab-grown blood vessel (ATEV) if they have no other treatment options and cannot join a clinical study. The vessel is designed to replace or bypass dam…
Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC